| Target Price | $341.70 |
| Price | $307.88 |
| Potential | 10.98% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target JPMorgan Chase & Co. 2026 . The average JPMorgan Chase & Co. target price is $341.70. This is 10.98% higher than the current stock price. The highest price target is $388.50 26.19% , the lowest is $252.50 17.99% . | |
| A rating was issued by 30 analysts: 19 Analysts recommend JPMorgan Chase & Co. to buy, 9 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the JPMorgan Chase & Co. stock has an average upside potential 2026 of 10.98% . Most analysts recommend the JPMorgan Chase & Co. stock at Purchase. |
24 Analysts have issued a sales forecast JPMorgan Chase & Co. 2025 . The average JPMorgan Chase & Co. sales estimate is $186b . This is 3.64% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $196b 9.32% , the lowest is $178b 0.76% .
This results in the following potential growth metrics:
| 2024 | $178b | 12.30% |
|---|---|---|
| 2025 | $186b | 4.72% |
| 2026 | $192b | 3.43% |
| 2027 | $200b | 3.73% |
| 2028 | $203b | 1.75% |
| 2029 | $211b | 3.76% |
| 2030 | $219b | 3.90% |
| 2031 | $228b | 4.19% |
| 2032 | $238b | 4.22% |
29 JPMorgan Chase & Co. Analysts have issued a net profit forecast 2025. The average JPMorgan Chase & Co. net profit estimate is $55.7b . This is 1.68% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $59.8b 5.54% , the lowest is $52.8b 6.77% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $56.9b | 19.07% |
|---|---|---|
| 2025 | $55.7b | 2.04% |
| 2026 | $58.2b | 4.41% |
| 2027 | $63.1b | 8.54% |
| 2028 | $64.2b | 1.69% |
| 2029 | $70.9b | 10.36% |
| 2030 | $76.4b | 7.88% |
| 2031 | $84.3b | 10.29% |
| 2032 | $93.0b | 10.37% |
| 2024 | 32.03% | 6.03% |
|---|---|---|
| 2025 | 29.96% | 6.46% |
| 2026 | 30.24% | 0.93% |
| 2027 | 31.64% | 4.63% |
| 2028 | 31.63% | 0.03% |
| 2029 | 33.64% | 6.35% |
| 2030 | 34.93% | 3.83% |
| 2031 | 36.97% | 5.84% |
| 2032 | 39.15% | 5.90% |
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 19.75 | 20.46 |
| 21.69% | 3.59% | |
| P/E | 15.10 | |
| EV/Sales | 10.25 |
29 Analysts have issued a JPMorgan Chase & Co. forecast for earnings per share. The average JPMorgan Chase & Co. EPS is $20.46 . This is 0.05% lower than earnings per share in the financial year 2024. The highest EPS forecast is $21.97 7.33% , the lowest is $19.40 5.23% .
This results in the following potential growth metrics and future valuations:
| 2024 | $19.75 | 21.69% |
|---|---|---|
| 2025 | $20.46 | 3.59% |
| 2026 | $21.37 | 4.45% |
| 2027 | $23.19 | 8.52% |
| 2028 | $23.58 | 1.68% |
| 2029 | $26.03 | 10.39% |
| 2030 | $28.08 | 7.88% |
| 2031 | $30.97 | 10.29% |
| 2032 | $34.18 | 10.36% |
| Current | 15.09 | 9.75% |
|---|---|---|
| 2025 | 15.10 | 0.06% |
| 2026 | 14.46 | 4.24% |
| 2027 | 13.32 | 7.88% |
| 2028 | 13.10 | 1.65% |
| 2029 | 11.87 | 9.39% |
| 2030 | 11.00 | 7.33% |
| 2031 | 9.98 | 9.27% |
| 2032 | 9.04 | 9.42% |
Based on analysts' sales estimates for 2025, the JPMorgan Chase & Co. stock is valued at an EV/Sales of 10.25 and an P/S ratio of 4.52 .
This results in the following potential growth metrics and future valuations:
| Current | 10.62 | 86.32% |
|---|---|---|
| 2025 | 10.25 | 3.53% |
| 2026 | 9.91 | 3.32% |
| 2027 | 9.55 | 3.60% |
| 2028 | 9.38 | 1.72% |
| 2029 | 9.04 | 3.62% |
| 2030 | 8.71 | 3.75% |
| 2031 | 8.36 | 4.02% |
| 2032 | 8.02 | 4.05% |
| Current | 4.69 | 83.09% |
|---|---|---|
| 2025 | 4.52 | 3.51% |
| 2026 | 4.37 | 3.32% |
| 2027 | 4.22 | 3.60% |
| 2028 | 4.14 | 1.72% |
| 2029 | 3.99 | 3.62% |
| 2030 | 3.84 | 3.75% |
| 2031 | 3.69 | 4.02% |
| 2032 | 3.54 | 4.05% |
JPMorgan Chase & Co....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Nov 03 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 15 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 07 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Sep 30 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 29 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Sep 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Nov 03 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 15 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 15 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 07 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Sep 30 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 29 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


